A B S T R A C T Objective: To systematically map the stepwise events leading to deoxyelephantopin-induced cell death of HCT116 human colorectal cancer cells and evaluate the effectiveness of deoxyelephantopin in vivo. Methods: HCT116 cells were treated with deoxyelephantopin at various concentrations and time points. Autophagy was confirmed by the detection of autophagosomes and autophagosomal proteins by electron microscopy and Western blotting assays, respectively, and then validated by siRNA knockdown. In addition, apoptosis was confirmed by the detection of apoptosis-related proteins. The intracellular reactive oxygen species (ROS) level was measured using flow cytometry. The growth inhibitory effect of deoxyelephantopin was further evaluated in vivo using a mouse xenograft model. Results: Deoxyelephantopin firstly elevated ROS production, which then triggered autophagic flux with the accumulation of autophagosomal proteins including LC3A/B, ATG5, and ATG7, followed by the induction of apoptosis via the intrinsic and extrinsic pathways. Pre-treatment with N-acetyl-L-cysteine, a ROS inhibitor, reversed both apoptosis and autophagy. The knockdown of LC3 prevented apoptosis induction which confirmed that deoxyelephantopin induced autophagy-dependent apoptosis in HCT116 cells. Accumulation of ROS also activated apoptosis via the mitogen-activated protein kinases signaling pathway. Furthermore, deoxyelephantopin also inhibited the PI3K/AKT/mTOR pathway,
Introduction
Colorectal carcinoma (CRC) is one of the most dreaded malignancies and causes high mortality worldwide [1] . Current treatment options for colorectal cancer include adjuvant or neoadjuvant chemotherapy [2] .
However, many of the chemotherapeutic agents used are associated with serious adverse effects, inadequate efficacy, and resistance development, which necessitate the continuous search for more efficacious and safer anti-CRC drugs.
Targeting signaling pathways that modulate apoptosis and autophagy remains an attractive strategy to inhibit cancer cell growth. Apoptosis or programmed cell death type 栺 is mediated via the intrinsic and extrinsic pathways involving the mitochondria and death receptors, respectively. Reactive oxygen species (ROS) generating agents can modulate apoptosis via the activation of the mitogen-activated protein aged/malfunctioning organelles or misfolded proteins via the interaction between autophagosomes and lysosomes, also plays an important role in determining tumor fate [4] . Autophagy can be either cytoprotective or cytodestructive. Exploiting autophagy with its pro-death effect will enhance the efficacy of chemotherapeutic agents [5] . Compounds such as rottlerin and betulinic acid have been reported to induce both autophagy and apoptosis in prostate cancer stem cells and HT29 cells, respectively [6, 7] . In addition, autophagy and apoptosis also share common signaling pathways such as phosphoinositide-3-kinase (PI3K)/protein kinase B (AKT)/ mammalian target of rapamycin (mTOR) and MAPK [3, 8, 9] .
Therefore, a drug that simultaneously targets multiple survival pathways could increase its efficacy in inhibiting tumor growth and restore the sensitivity of the tumor cells to its cytotoxic effects.
To date, there remains strong interests to discover naturally-derived anti-cancer agents that target multiple signaling pathways important for tumor growth and progression, as alternatives for safer and more efficacious drugs [10, 11] . Deoxyelephantopin (DET) is one of the major bioactive compounds isolated from Elephantopus scaber L., a popular Ayurvedic herb employed for the treatment of cancer, hepatitis, bronchitis, pneumonia and fever [12, 13] . Previous studies have demonstrated the potentials of utilizing DET to target breast, cervical, nasopharyngeal, lung and liver cancer cells via various cell death mechanisms including apoptosis, cell cycle arrest, autophagy, paraptosis involving oxidative stress, nuclear factor-kappa B (NF-毷 B), PI3K/AKT, signal transducer and activator of transcription (STAT) and MAPK signaling pathways [14] [15] [16] [17] [18] [19] . Our previous findings revealed that DET is a highly potent cytotoxic agent (IC 50 = 0.73 μg/mL) against HCT116 cells [20, 21] in comparison to normal colon cells. Thus far, it is known that DET could induce HCT116 cell death via apoptosis and/or autophagy [17] but the stepwise events leading to cell death and the exact interplay between autophagy and apoptosis remains to be defined further. Moreover, the effect of DET has not been validated in vivo for CRC. Here, we used HCT116 cells as a model to systematically map the stepwise events leading to cell death and to investigate the anti-cancer effect of DET in vivo and identify the mechanisms involved.
Materials and methods

Reagents and antibodies
DET (purity ≥ 98%) was isolated from Elephantopus scaber L. and identified using spectroscopic analysis ( 1 H, 13 C NMR and HRESI-MS) as reported previously [20] . Roswell Park Memorial Institute 
Cell culture
HCT116 cells were obtained from the American Type Culture Collection (Manassas, VA, USA). All cells were cultured in RPMI 1640 medium supplemented with 10% v/v heat-inactivated fetal bovine serum, and 0.01% antimycotic solution. The cells were maintained at 37 曟 in a humidified atmosphere with 5% CO 2 . 
Protein array analysis
Detection of mitochondrial membrane potential
Mitochondrial dysfunction is often associated with changes in mitochondrial membrane potential which can be examined by using the cell-permeable fluorescent cationic dye, mito-ID. HCT116 cells (1 伊 10 6 cells) were cultured in 60 mm 2 culture for 24 h followed by treatment with different concentrations (0.75-3.0 μg/mL) of DET or vehicle DMSO only (untreated control) for 24 h. Subsequently, the cells were harvested and washed. The cell pellet was resuspended with culture media containing mito-ID and incubated at 37 曟 in 5% CO 2 incubator for 15 min. Then, cell suspension was washed and replaced with growth medium. The detection of green and red fluorescence signals in FL1-A and FL2-A channels was performed using flow cytometry.
Detection of acidic vesicular organelles
To detect acidic vesicular organelle, cells were stained with AO and visualized by fluorescence microscopy. HCT116 cells (1 伊 10 6 cells) were treated with or without DET in the presence or absence of NAC for 24 h. After treatment, the cells were harvested, washed and incubated with 1 μg/mL of AO for 15 min at 37 曟 and then washed again with PBS. The cells were viewed under a fluorescent microscope.
Transmission electron microscopy (TEM)
To elucidate the formation of autophagosomes mediated by DET in HCT116 cells, ultrastructural alterations were visualized by TEM.
The treated cells were harvested and fixed with 4% glutaraldeyde and further fixed with 1% osmium tetroxide, which was followed by a series of dehydration process in increasing concentrations of alcohol. The cells were then further embedded in epon resin.
Ultrathin sections were obtained by using an ultramicrotome (Leica Ultracut, Germany). The sections were placed onto copper grids and stained with uranyl acetate replacement and lead citrate.
Subsequently, the sections were analyzed by Carl Zeiss Libra 120 energy filtering transmission electron microscope (Oberkochen,
Germany). Next, the membranes were incubated with primary antibodies at 4 曟 overnight and then washed with 0.05% Tween 20 in tris-buffered saline (TBST). Next, the membrane was incubated with corresponding antimouse/rabbit immunoglobulin G-horseradish peroxidase-conjugated secondary antibody for 1 h at room temperature and washed thrice with TBST. Finally, the membrane was incubated with enhanced chemiluminescence reagent and visualized using a gel documentation system. The protein band intensities were quantitated using Vilber Lourmart software. 
Western blotting analysis
Treatment with apoptosis and autophagy inhibitors
Treatment with p38, JNK and ERK specific inhibitors
To assess the involvement of MAPK pathway in DET-induced apoptosis, p38 specific inhibitor (SB202190), JNK specific inhibitor (SP600125) and ERK specific inhibitor (UO126) were used to inhibit the activation of this pathway prior to DET treatment. Briefly, HCT116 cells were pre-incubated with 10 μM of SB202190 or 5 μM of SP600125 or 5 μM of UO126, respectively, for 1 h prior to treatment with DET (3.0 μg/mL) for 24 h. Total proteins of the treated cells were then harvested for Western blotting analysis. 
Ethics statement
Human CRC xenograft experiment
Immunohistochemical (IHC) analysis
For IHC staining, paraffin-embedded tumors were sectioned into 4 μm thick and were deparaffinized in xylene and hydrated with graded alcohol, and incubated with 0.3% hydrogen peroxide (H 2 O 2 ) for 10 min. Antigen unmasking was carried out by incubating slides in boiled 10 mM sodium citrate buffer (pH 6.0) for 30 min. The slides were then blocked with 5% normal goat serum for 1 h at room temperature and followed by incubation with antibodies overnight at 4 曟 . Subsequently, the slides were washed three times with wash buffer (1 伊 TBST) and incubated with secondary antibody for 30 min at room temperature. The slides were washed with TBST for three times for 5 min and exposed to 3, 3'-diaminobenzidine chromogen and counterstained in hematoxylin. For quantification, three random 伊 400 microscopic fields per slide were captured using an inverted microscope Nikon Eclipse TS100 (Nikon, Japan) and analyzed using Nikon NIS-BR element software (Nikon, Japan).
Statistical analysis
All assays were performed in at least three separate experiments and the data were stated as mean ± standard error (SE). Statistical analyses were performed using one-way analysis of variance (ANOVA) followed by Dunnett's test or Student's t-test, where applicable. P value < 0.05 was regarded statistically significant. 
Results
Intrinsic and extrinsic apoptosis in HCT116 cancer cells induced by DET treatment
DET induced autophagy in HCT116 cancer cells
Inhibition of autophagy induced apoptosis while the inhibition of apoptosis promoted autophagy in DET-treated cells
Co-treatment with 3-MA reduced the expression of LC3A/B-栻 , indicating that the induction of autophagy was mitigated ( Figure 3A 
Inhibition of apoptosis via knockdown of LC3
The pro-death effect of autophagy induced by DET was further confirmed by silencing LC3, which facilitated the formation of autophagosomes. The protein expression of LC3 was firstly assessed by Western blotting analysis to determine the knockdown efficiency of three unique siRNA duplexes targeting LC3 (siRNA A, B and C). Among the three siRNA duplexes, siRNA C gave the highest knockdown efficiency, with ~85.9% protein expression suppression ( Figure 3F and G) with viability >100% (Supplementary Figure 1) in HCT116 cells and hence, siRNA C was chosen for subsequent experiments. Accumulation of LC3A/B-栻 was significantly reduced after transfection with siRNA LC3 prior to the treatment with DET ( Figure 3H ). Knockdown of LC3 expression partially reversed DETinduced cytotoxicity in HCT116 cells ( Supplementary Figure 1) .
Furthermore, the expression of apoptosis marker, cleaved PARP was reduced, indicating the apoptotic effect triggered by DET was interrupted in the absence of autophagy ( Figure 3H and I) .
These findings confirmed that DET activates autophagy-dependent apoptosis in HCT116 cells.
Oxidative stress and ROS-dependent autophagy followed by apoptosis in HCT116 cells upon DET treatment
Upon exposure to increasing concentrations of DET (0.75, 1.5 and 3.0 μg/mL), the intracellular ROS level was significantly elevated ( Figure 4A and B) . The production of ROS was completely abolished by pre-treatment with NAC, a ROS inhibitor in the DETtreated cells ( Figure 4C ). In addition, the percentage of viable DETtreated cells also increased in the presence of NAC when compared to those without NAC ( Figure 4D ). This result confirmed that DET induces ROS production in HCT116 cells.
To investigate the association between DET-induced ROS generation and autophagy, ultrastructural changes of the cells, Figure 4E and F) . These findings indicated that DET-mediated autophagy is caused by the production of ROS in HCT116 cells. Furthermore, the activation of apoptosisrelated proteins by DET including cleaved caspase-3, cleaved PARP and DR5 proteins was suppressed while the procaspase-9 and -10
were increased in the presence of NAC ( Figure 4G and H) .
ROS-dependent MAPK pathway activation induced by DET treatment
In the present study, it was observed that DET induced a timedependent increase in the expression of phosphorylated ERK1/2, JNK and p38 proteins ( Figure 5A and B) , indicating that the activation of MAPK is required for DET-induced apoptosis. We further investigated the potential of ROS in activating apoptosis via MAPK pathway triggered by DET. In the presence of NAC, the phosphorylation of ERK1/2, JNK and p38 MAPK proteins were Figure 6 ). These data suggested that DET inhibits PI3K/AKT/mTOR pathway in HCT116 cells.
Inhibition of the growth of HCT116 cells in vivo by DET
The in vivo effect of DET on CRC was examined in mice tumor xenograft. As illustrated in Figure 7A , the body weights of all mice groups did not significantly change except for mice treated with 50 mg/kg of 5-fluorouracil, in which there was a significant reduction in tumor sizes and all mice died by day 10 likely from 5-fluorouracil toxicity associated with the dose used ( Figure 7B ). Tumor sizes were significantly reduced when the mice were treated with 1.25 and 2.5 mg/kg DET ( Supplementary Figure 3) . In the 2.5 mg/kg DET-treated group, the tumor volumes were significantly reduced by 73.48% after 28 days of DET administration ( Figure 7B ). In Hence, both in vivo and in vitro findings showed that DET induces colorectal cancer cell death via apoptosis and autophagy.
Discussion
DET has garnered a lot of attention as an effective anti-cancer agent owing to its anti-migration, anti-angiogenesis and antitumor effects [18, 23, 17] by targeting multiple signaling pathways important for cancer cell proliferation [24] . We previously reported that DET induces cell cycle arrest and apoptosis in HCT116 colorectal cells [20] . Based on previous evidence of its effectiveness in suppressing growth of many cancer cell types, the present study aims to map the stepwise events leading to cell death by examining the interplay between apoptosis and autophagy using HCT116 as a model as well as to provide in vivo evidence for the effectiveness of DET in targeting CRC.
Apoptosis is often a major target in the development of novel cancer chemotherapy [25, 4, 26] . Results from the present study showed that to support our previous preliminary study on DET inhibition of HCT116 cell growth through apoptosis and cell cycle arrest [20] .
The intricate interplay between autophagy and apoptosis is reported [29] , but how DET modulates the series of events leading to autophagy and apoptosis activation has yet to be reported.
Accumulation of autophagy proteins (LC3A/B-栻 , ATG7 and ATG5) following treatment with DET was observed and this finding is in agreement with previous reports [30, 31] . been reported [32, 33] .
Anti-cancer agents such as oxaliplatin, capsaicin and curcumin are known to induce oxidative stress and apoptotic responses via ROS production [34] [35] [36] . In the present study, dose-dependent increase of ROS generation in HCT116 cells upon DET treatment was observed.
In addition, there was an accumulation of AO-stained acidic vesicular organelles and autophagosomes, which occurred hours after the elevation of ROS in HCT116 cells. These findings confirmed that DET triggers excessive production of ROS in HCT116 cells, which appears to be an early event in the induction of cell death.
MAPK is a central signaling pathway that is involved in cell proliferation and differentiation, whereby, activation of JNK and p38
MAPKs generally promotes apoptosis while activation of ERK1/2 promotes cell proliferation [3] . However, there was new evidence that showed anti-cancer agents could prolong the activation of ERK1/2 and promote apoptosis in cancer cells. For instance, taxol has been shown to induce apoptosis via the activation of ERK in MCF7 cells [37] while hispolon from the fungus Phellinus linteus has been shown to induce apoptosis via the phosphorylation of ERK1/2, p38 MAPK and JNK1/2 pathways in human nasopharyngeal cancer cells [38] . For instance, neoalbaconol induces multiple cell death pathways in nasopharyngeal cancer cells by inhibiting PI3K/AKT/mTOR signaling pathway [39] . Our findings revealed that DET-induced apoptosis could also be attributed to the inhibition of AKT phosphorylation as evidenced by the suppression of PDK1 and AKT phosphorylation at the site of Thr308/Ser473. Further downstream of the PI3K/AKT pathway is another mediator of cell survival, mTOR which consists of mTORC1 and mTORC2 with their respective regulatory proteins, RAPTOR and rapamycin-insensitive companion of mammalian target of rapamycin (RICTOR) [40] . Our current findings revealed that DET abrogated the phosphorylation of mTOR. mTOR can be activated by Ras homolog enriched in brain (Rheb).
Rheb activation is directly inhibited by tuberous sclerosis 2 (TSC2)-TSC1 complex. Activation of ERK activates the TSC2-TSC1 complex whereas activation of AKT increases TSC2 phosphorylation resulting in the dissociation of the TSC2-TSC1 complex [41, 42] .
Hence, increased ERK activation and decreased phosphorylation of AKT which led to the overall inhibition of mTOR following DET treatment could be mediated through the activation of TSC2-TSC1
and Rheb downregulation. In addition, inactivation of mTORC1 could also stimulate the formation of the Unc-51-like kinase 1 (ULK 1)-containing pro-autophagic complex which ultimately leads to the formation of autophagosomes [43] . Thus, findings from the present study support the involvement of PI3K/AKT/mTOR pathway in the induction of both apoptosis and autophagy by DET.
Thus far, the in vivo anti-tumor efficacy of DET on human colorectal cancer cells has yet to be reported. Through our mouse xenograft study, it is observed that DET significantly inhibited tumor growth and also enhanced the survival of mice. Importantly, DET did not cause significant weight loss in mice and produced no apparent sign of toxicity. These findings are in agreement to those of a previous toxicity study which demonstrated that the maximum tolerated dose for DET is 40 mg/kg in the mice [44] . Colorectal tumorigenesis is a result from dysregulation of apoptosis and aberrant cell proliferation which is often associated with proliferative proteins such as PCNA [45] . Notably, our in vivo data of DET inhibition of tumor cell growth is substantiated by the drastically lower PCNA labelling index compared to the control mice group as demonstrated by immunohistochemical analysis. The lower PCNA expression is also consistent with in vitro findings from our previous study whereby, DET inhibits cell proliferation through cell cycle arrest at S phase in HCT116 cells [20] . In addition, immunohistochemical findings also showed that DET reduced Bcl-2 and elevated BAX, cleaved caspase-3 and LC3 expressions which corroborated findings from our in vitro studies.
In summary, our study has demonstrated that DET from Elephantopus scaber L. exerts significant in vitro and in vivo anti-tumor effects in HCT116 human CRC through the generation of ROS and induction of autophagy-dependent apoptosis. DET induces ROS-dependent apoptosis and autophagy by targeting multiple pathways including MAPK and PI3K/AKT/mTOR (Figure 8 ). It is proposed that DETinduced autophagy precedes apoptosis, which is mediated in concert with the inhibition of PI3K/Akt/mTOR signaling and activation of ROS-dependent MAPK pathway (Figure 8 ). Taken together, the ability of DET to alter these prominent signaling pathways in controlling cancer cell growth signifies the enormous potential of DET to be developed as a multi-target therapeutic agent for colorectal cancer.
